{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05423210",
            "orgStudyIdInfo": {
                "id": "SBU-FSRT-NEURO"
            },
            "organization": {
                "fullName": "Stony Brook University",
                "class": "OTHER"
            },
            "briefTitle": "Atezolizumab and Pre-Surgical Brain Radiation Therapy for Glioblastoma Multiforme",
            "officialTitle": "A Pilot Study to Evaluate the Immunogenic Effects of Window-of-Opportunity Fractionated Stereotactic Radiotherapy Combined With Atezolizumab for Patients With Newly Diagnosed WHO CNS Grade 4 Glioma (Glioblastoma Multiforme)",
            "therapeuticArea": [
                "Other"
            ],
            "study": "atezolizumab-and-pre-surgical-brain-radiation-therapy-for-glioblastoma-multiforme"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-02",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2022-10-25",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2026-08",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2026-08",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2022-06-14",
            "studyFirstSubmitQcDate": "2022-06-14",
            "studyFirstPostDateStruct": {
                "date": "2022-06-21",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-02-22",
            "lastUpdatePostDateStruct": {
                "date": "2024-02-26",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "PRINCIPAL_INVESTIGATOR",
                "investigatorFullName": "Alexander Stessin",
                "investigatorTitle": "Professor of Medicine",
                "investigatorAffiliation": "Stony Brook University"
            },
            "leadSponsor": {
                "name": "Stony Brook University",
                "class": "OTHER"
            },
            "collaborators": [
                {
                    "name": "Genentech, Inc.",
                    "class": "INDUSTRY"
                }
            ]
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "This is a single-arm pilot study that will recruit 12 patients with newly diagnosed Glioblastoma, a malignant brain tumor with a poor prognosis. Patients will be treated with fractionated stereotactic radiotherapy (FSRT) for 2 weeks, in addition to two doses of Atezolizumab (Tecentriq), an FDA approved PD- L1 inhibitor drug, 840 mg IV, at the beginning and at the end of the two-week time period, concomitantly with FSRT. After this initial two weeks treatment the patients will undergo craniotomy and maximal safe resection as per normal care for a GB. After surgery patients will follow the normal care for glioblastoma in addition to Atezolizumab 840 mg IV q2 weeks for the duration of adjuvant treatment."
        },
        "conditionsModule": {
            "conditions": [
                "Glioblastoma Multiforme"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "EARLY_PHASE1"
            ],
            "designInfo": {
                "allocation": "NA",
                "interventionModel": "SINGLE_GROUP",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 12,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Treatment",
                    "type": "EXPERIMENTAL",
                    "interventionNames": [
                        "Combination Product: Atezolizumab + FSRT radiation"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "COMBINATION_PRODUCT",
                    "name": "Atezolizumab + FSRT radiation",
                    "description": "Atezolizumab 840mg IV every 2 weeks Fractionated Stereotactic Radiotherapy",
                    "armGroupLabels": [
                        "Treatment"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Number of participants who progress/relapse after surgical resection",
                    "description": "Assess the efficacy of atezolizumab in combination with fractionated stereotactic radiation therapy in the neoadjuvant setting for resectable glioblastoma multiforme",
                    "timeFrame": "2 years"
                },
                {
                    "measure": "Number of participants with treatment-related adverse events as assessed by CTCAE v5.0",
                    "description": "Assess the safety of atezolizumab in combination with fractionated stereotactic radiation therapy in the neoadjuvant setting for resectable glioblastoma multiforme",
                    "timeFrame": "30 days after the last dose of atezolizumab"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Diagnosis of glioblastoma multiforme WHO Grade IV\n* The patient is a surgical candidate, with the surgical intent for a \\> 80% resection of the lesion\n* Negative pregnancy test\n* ECOG status \\<= 2\n* Tumor volume \\<= 3.5 cm\n* Adequate organ function\n* Negative for infectious disease (human immunodeficiency virus, Hepatitis B Virus, Hepatitis C Virus, tubercolosis)\n\nExclusion Criteria:\n\n* Presence of leptomeningeal disease, gliomatosis cerebri, multifocal disease, bilateral cerebral hemisphere involvement (\"butterfly\" gliomas)\n* Patients at increased risk of neurologic decompensation\n* Continued use of high dose intravenous or oral corticosteroids, or \\> 8milligrams per day of systemic dexamethasone\n* Uncontrolled tumor-related pain\n* Uncontrolled pleural effusion, pericardial effusion, or ascites requiring recurrent drainage procedures (once monthly or more frequently)\n* Uncontrolled or symptomatic hypercalcemia\n* History of autoimmune disease or immune deficiency\n* History of idiopathic pulmonary fibrosis, organizing pneumonia (e.g., bronchiolitis obliterans), drug-induced pneumonitis, or idiopathic pneumonitis, or evidence of active pneumonitis\n* Significant cardiovascular disease\n* History of other malignancy within 1 year prior to screening\n* Severe infection within 4 weeks prior to initiation of study treatment\n* History of allogeneic stem cell or organ transplant\n* Prior treatment with CD137 agonists or immune checkpoint blockade therapies\n* Treatment with systemic immunostimulatory agents\n* Treatment with systemic immunosuppressive medication",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Catherine Izzo, MS",
                    "role": "CONTACT",
                    "phone": "631-372-7212",
                    "email": "catherine.izzo@stonybrookmedicine.edu"
                },
                {
                    "name": "Alexander Stessin, MD",
                    "role": "CONTACT",
                    "phone": "631-638-1000",
                    "email": "alexander.stessin@stonybrookmedicine.edu"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Alexander Stessin, MD",
                    "affiliation": "Stony Brook Cancer Center",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "Stony Brook University Hospital",
                    "status": "RECRUITING",
                    "city": "Stony Brook",
                    "state": "New York",
                    "zip": "11794",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Alexander M Stessin, MD",
                            "role": "CONTACT",
                            "phone": "631-444-2200",
                            "email": "alexander.stessin@stonybrookmedicine.edu"
                        },
                        {
                            "name": "Caterina Vacchi-Suzzi, PhD",
                            "role": "CONTACT",
                            "phone": "631-216-2993",
                            "email": "caterina.vacchi-suzzi@stonybrookmedicine.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.92565,
                        "lon": -73.14094
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000005909",
                    "term": "Glioblastoma"
                }
            ],
            "ancestors": [
                {
                    "id": "D000001254",
                    "term": "Astrocytoma"
                },
                {
                    "id": "D000005910",
                    "term": "Glioma"
                },
                {
                    "id": "D000018302",
                    "term": "Neoplasms, Neuroepithelial"
                },
                {
                    "id": "D000017599",
                    "term": "Neuroectodermal Tumors"
                },
                {
                    "id": "D000009373",
                    "term": "Neoplasms, Germ Cell and Embryonal"
                },
                {
                    "id": "D000009370",
                    "term": "Neoplasms by Histologic Type"
                },
                {
                    "id": "D000009369",
                    "term": "Neoplasms"
                },
                {
                    "id": "D000009375",
                    "term": "Neoplasms, Glandular and Epithelial"
                },
                {
                    "id": "D000009380",
                    "term": "Neoplasms, Nerve Tissue"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M9020",
                    "name": "Glioma",
                    "relevance": "LOW"
                },
                {
                    "id": "M9019",
                    "name": "Glioblastoma",
                    "asFound": "Glioblastoma Multiforme",
                    "relevance": "HIGH"
                },
                {
                    "id": "M4561",
                    "name": "Astrocytoma",
                    "relevance": "LOW"
                },
                {
                    "id": "M20446",
                    "name": "Neoplasms, Neuroepithelial",
                    "relevance": "LOW"
                },
                {
                    "id": "M19845",
                    "name": "Neuroectodermal Tumors",
                    "relevance": "LOW"
                },
                {
                    "id": "M20388",
                    "name": "Neuroectodermal Tumors, Primitive",
                    "relevance": "LOW"
                },
                {
                    "id": "M12318",
                    "name": "Neoplasms, Germ Cell and Embryonal",
                    "relevance": "LOW"
                },
                {
                    "id": "M12315",
                    "name": "Neoplasms by Histologic Type",
                    "relevance": "LOW"
                },
                {
                    "id": "M12320",
                    "name": "Neoplasms, Glandular and Epithelial",
                    "relevance": "LOW"
                },
                {
                    "id": "M12325",
                    "name": "Neoplasms, Nerve Tissue",
                    "relevance": "LOW"
                },
                {
                    "id": "T2519",
                    "name": "Glioma",
                    "relevance": "LOW"
                },
                {
                    "id": "T2518",
                    "name": "Glioblastoma",
                    "asFound": "Glioblastoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "T4092",
                    "name": "Neuroepithelioma",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC04",
                    "name": "Neoplasms"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "C000594389",
                    "term": "Atezolizumab"
                }
            ],
            "ancestors": [
                {
                    "id": "D000082082",
                    "term": "Immune Checkpoint Inhibitors"
                },
                {
                    "id": "D000045504",
                    "term": "Molecular Mechanisms of Pharmacological Action"
                },
                {
                    "id": "D000074322",
                    "term": "Antineoplastic Agents, Immunological"
                },
                {
                    "id": "D000000970",
                    "term": "Antineoplastic Agents"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M349417",
                    "name": "Atezolizumab",
                    "asFound": "Status",
                    "relevance": "HIGH"
                },
                {
                    "id": "M2342",
                    "name": "Immune Checkpoint Inhibitors",
                    "relevance": "LOW"
                },
                {
                    "id": "M1346",
                    "name": "Antineoplastic Agents, Immunological",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "ANeo",
                    "name": "Antineoplastic Agents"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                }
            ]
        }
    },
    "hasResults": false
}